Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019

in response to

Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019

BearDownAZ

posted on Dec 02, 2019 02:42PM

Good Endpoints article on Biogen.

https://endpts.com/analyst-brian-skorney-goes-grizzly-on-biogens-alzheimers-hype-fearmongering-and-statistical-malpractice/

Also, forgive my perpetuation of confusion. Biogen's Aducanumab and BAN2401 are two separate drugs that both tackle amyloid. I previously implied that they were one and the same.